Target intelligence / Profile preview

Bacterial cell wall synthesis machinery

Molecular classification
Enzyme complex, Multi-protein assembly, Other (includes various enzymes, scaffolding proteins, and regulatory factors)
01

Overview

The **bacterial cell wall synthesis machinery** refers to a dynamic multi-protein complex responsible for the construction and remodeling of the bacterial cell wall, primarily through the synthesis and cross-linking of peptidoglycan. Peptidoglycan is a mesh-like polymer composed mainly of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues linked by β(1→4) glycosidic bonds. These sugar chains are cross-linked via short peptide stems containing unusual amino acids such as D-alanine and meso-diaminopimelic acid, providing structural strength[1][2]. The machinery includes numerous essential enzymes such as Mur family ligases, glycosyltransferases, transpeptidases (penicillin-binding proteins), carboxypeptidases, as well as regulatory scaffolding proteins that coordinate spatially regulated growth during elongation or division[2][3][4]. This system is a major target for many clinically important antibiotics; disruption leads to loss of structural integrity and ultimately bacterial death. The composition can vary between Gram-positive and Gram-negative bacteria but is universally critical for most pathogenic species. Resistance mechanisms—such as altered target sites or enzymatic drug degradation—pose significant therapeutic challenges.

Other names
Peptidoglycan synthesis machineryCell wall biosynthesis complexBacterial peptidoglycan assembly system
02

Mechanism of action

Inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins or D-Ala-D-Ala termini in the growing cell wall, leading to weakened cell walls and bacterial lysis

03

Biological functions

Cell wall biosynthesisMaintenance of cell shape and integrityRegulation of cell division and growthProtection against osmotic stress
04

Disease associations

Infection (targeted by antibiotics to treat bacterial infections)
05

Safety considerations

Development of antibiotic resistance due to mutations or acquisition of resistance genes in bacteria targeting this pathway.
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillins, cephalosporins)

1 more in the full profile.

Beyond the preview

Go deeper on Bacterial cell wall synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call